TipRanks
Biosergen AB (SE:BIOSGN)
:BIOSGN
Sweden Market
BIOSGN
Biosergen AB
RESEARCH TOOLSreports
Want to see SE:BIOSGN full AI Analyst Report?

Biosergen AB (BIOSGN) Income Statement

0 Followers

Biosergen AB Income Statement

Last quarter (Q2 2026), Biosergen AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q2, Biosergen AB's net income was kr-5.24M. See Biosergen AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 8.57M
Gross Profit
kr 0.00kr 0.00kr -456.00Kkr -280.00Kkr -213.60K
Operating Expenses
kr 41.39Mkr 20.69Mkr 26.81Mkr 33.85Mkr 40.68M
Depreciation and Amortization
kr 0.00kr 0.00kr 27.27Mkr 0.00kr 0.00
EBITDA
kr -40.84Mkr -19.20Mkr 228.00Kkr -34.05Mkr -34.32M
Operating Income
kr -41.39Mkr -20.69Mkr -27.27Mkr -34.13Mkr -33.71M
Other Income/Expenses
kr 486.00Kkr 1.50Mkr 228.00Kkr 81.00Kkr -612.00K
Pretax Income
kr -40.82Mkr -19.20Mkr -27.04Mkr -34.05Mkr -34.32M
Net Income
kr -40.82Mkr -19.20Mkr -27.04Mkr -34.05Mkr -34.32M
Per Share Metrics
Basic EPS
kr -1.90kr -0.88kr -6.57kr -11.94kr -7.01
Diluted EPS
kr -1.90kr -0.88kr -6.57kr -11.94kr -7.01
Weighted Average Shares Outstanding
 21.44M 21.91M 4.10M 4.82M 4.88M
Weighted Average Shares Outstanding (Diluted)
 21.44M 21.91M 4.10M 4.82M 4.88M
Currency in SEK

Biosergen AB Earnings and Revenue History